Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127046601 | 12704660 | 1 | I | 20160729 | 20160823 | 20160831 | 20160831 | EXP | FR-ASTRAZENECA-2016SE91376 | ASTRAZENECA | 17284.00 | DY | F | Y | 0.00000 | 20160831 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127046601 | 12704660 | 1 | PS | INEXIUM | ESOMEPRAZOLE | 1 | Oral | Y | U | 21153 | 40 | MG | QD | ||||||
| 127046601 | 12704660 | 2 | SS | ADVAGRAF | TACROLIMUS | 1 | Oral | Y | U | 0 | 2.5 | MG | QD | ||||||
| 127046601 | 12704660 | 3 | SS | ADVAGRAF | TACROLIMUS | 1 | Oral | Y | U | 0 | 2.5 | MG | QD | ||||||
| 127046601 | 12704660 | 4 | SS | ADVAGRAF | TACROLIMUS | 1 | Oral | Y | U | 0 | 2 | DF | QD | ||||||
| 127046601 | 12704660 | 5 | SS | SEROPLEX | ESCITALOPRAM OXALATE | 1 | Oral | Y | U | 0 | |||||||||
| 127046601 | 12704660 | 6 | SS | XANAX | ALPRAZOLAM | 1 | Oral | Y | U | 0 | |||||||||
| 127046601 | 12704660 | 7 | SS | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 10.0MG UNKNOWN | Y | U | 0 | 10 | MG | ||||||
| 127046601 | 12704660 | 8 | C | BISOPROLOL | BISOPROLOL | 1 | 0 | ||||||||||||
| 127046601 | 12704660 | 9 | C | TRIATEC | RAMIPRIL | 1 | 0 | ||||||||||||
| 127046601 | 12704660 | 10 | C | KAYEXALATE | SODIUM POLYSTYRENE SULFONATE | 1 | 0 | ||||||||||||
| 127046601 | 12704660 | 11 | C | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | 0 | 500 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127046601 | 12704660 | 1 | Abdominal pain upper |
| 127046601 | 12704660 | 2 | Prophylaxis against transplant rejection |
| 127046601 | 12704660 | 3 | Prophylaxis against transplant rejection |
| 127046601 | 12704660 | 4 | Prophylaxis against transplant rejection |
| 127046601 | 12704660 | 5 | Depression |
| 127046601 | 12704660 | 6 | Anxiety |
| 127046601 | 12704660 | 7 | Cardiovascular event prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127046601 | 12704660 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127046601 | 12704660 | Alanine aminotransferase increased | |
| 127046601 | 12704660 | Aspartate aminotransferase increased | |
| 127046601 | 12704660 | Blood alkaline phosphatase increased | |
| 127046601 | 12704660 | Gamma-glutamyltransferase increased | |
| 127046601 | 12704660 | Hepatitis cholestatic | |
| 127046601 | 12704660 | Ischaemic stroke |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127046601 | 12704660 | 1 | 201607 | 20160729 | 0 | |
| 127046601 | 12704660 | 2 | 201607 | 0 | ||
| 127046601 | 12704660 | 5 | 201607 | 20160729 | 0 | |
| 127046601 | 12704660 | 6 | 201607 | 20160729 | 0 | |
| 127046601 | 12704660 | 7 | 20160729 | 0 |